Surmodics | SRDX - Current Liabilities

Surmodics reported $17.26M in Current Liabilities for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Current Liabilities Change
Align Technology ALGN:US USD 1.93B 116.48M
Anika Therapeutics ANIK:US USD 27.91M 1.56M
Arrowhead Research ARWR:US USD 122.01M 16.84M
Baxter International BAX:US USD 4.74B 1.04B
Bioscrip BIOS:US USD 565.35M 21.45M
Cryolife CRY:US USD 49.68M 3.68M
Edap Tms EDAP:US EUR 19.8M 3.59M
Edwards Lifesciences EW:US USD 1.02B 104.5M
Haemonetics HAE:US USD 226.89M 35.29M
Heron Therapeutics HRTX:US USD 82.35M 11.52M
Merit Medical Systems MMSI:US USD 220.64M 7.61M
Mesa Laboratories MLAB:US USD 41.62M 111K
Nektar Therapeutics NKTR:US USD 68.2M 15.78M
Stryker SYK:US USD 6.3B 1.73B
Surmodics SRDX:US USD 17.26M 14.82M